Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects

Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects Nora E. Straznicky 1 , Elisabeth A. Lambert 1 , Paul J. Nestel 2 , Mariee T. McGrane 1 , Tye Dawood 1 , Markus P. Schlaich 3 , Kazuko Masuo 1 , Nina Eikelis 1 , Barbora de Courten...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 59; no. 1; pp. 71 - 79
Main Authors Straznicky, Nora E., Lambert, Elisabeth A., Nestel, Paul J., McGrane, Mariee T., Dawood, Tye, Schlaich, Markus P., Masuo, Kazuko, Eikelis, Nina, de Courten, Barbora, Mariani, Justin A., Esler, Murray D., Socratous, Florentia, Chopra, Reena, Sari, Carolina I., Paul, Eldho, Lambert, Gavin W.
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.01.2010
Subjects
Online AccessGet full text
ISSN0012-1797
1939-327X
1939-327X
DOI10.2337/db09-0934

Cover

Abstract Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects Nora E. Straznicky 1 , Elisabeth A. Lambert 1 , Paul J. Nestel 2 , Mariee T. McGrane 1 , Tye Dawood 1 , Markus P. Schlaich 3 , Kazuko Masuo 1 , Nina Eikelis 1 , Barbora de Courten 4 , Justin A. Mariani 5 , Murray D. Esler 1 , Florentia Socratous 3 , Reena Chopra 1 , Carolina I. Sari 1 , Eldho Paul 6 and Gavin W. Lambert 1 1 Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 2 Cardiovascular Nutrition Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 3 Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 4 Clinical Physiology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 5 Heart Failure Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 6 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Corresponding author: Nora E. Straznicky, nora.straznicky{at}bakeridi.edu.au . Abstract OBJECTIVE Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. RESEARCH DESIGN AND METHODS Untreated men and women (mean age 55 ± 1 year; BMI 32.3 ± 0.5 kg/m 2 ) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. RESULTS Body weight decreased by −7.1 ± 0.6 and −8.4 ± 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 ± 4% ( P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by −96 ± 30 and −101 ± 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by −12 ± 6 and −19 ± 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. CONCLUSIONS The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received June 28, 2009. Accepted October 4, 2009. © 2010 American Diabetes Association
AbstractList Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects Nora E. Straznicky 1 , Elisabeth A. Lambert 1 , Paul J. Nestel 2 , Mariee T. McGrane 1 , Tye Dawood 1 , Markus P. Schlaich 3 , Kazuko Masuo 1 , Nina Eikelis 1 , Barbora de Courten 4 , Justin A. Mariani 5 , Murray D. Esler 1 , Florentia Socratous 3 , Reena Chopra 1 , Carolina I. Sari 1 , Eldho Paul 6 and Gavin W. Lambert 1 1 Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 2 Cardiovascular Nutrition Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 3 Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 4 Clinical Physiology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 5 Heart Failure Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; 6 Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Corresponding author: Nora E. Straznicky, nora.straznicky{at}bakeridi.edu.au . Abstract OBJECTIVE Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. RESEARCH DESIGN AND METHODS Untreated men and women (mean age 55 ± 1 year; BMI 32.3 ± 0.5 kg/m 2 ) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. RESULTS Body weight decreased by −7.1 ± 0.6 and −8.4 ± 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 ± 4% ( P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by −96 ± 30 and −101 ± 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by −12 ± 6 and −19 ± 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. CONCLUSIONS The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received June 28, 2009. Accepted October 4, 2009. © 2010 American Diabetes Association
Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. Untreated men and women (mean age 55 +/- 1 year; BMI 32.3 +/- 0.5 kg/m(2)) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. Body weight decreased by -7.1 +/- 0.6 and -8.4 +/- 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 +/- 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 +/- 30 and -101 +/- 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 +/- 6 and -19 +/- 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.
OBJECTIVE--Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. RESEARCH DESIGN AND METHODS--Untreated men and women (mean age 55 ± 1 year; BMI 32.3 ± 0.5 kg/[m.sup.2]) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. RESULTS--Body weight decreased by -7.1 ± 0.6 and -8.4 ± 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 ± 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 ± 30 and -101 ± 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 ± 6 and -19 ± 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. CONCLUSIONS--The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.
OBJECTIVE--Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. RESEARCH DESIGN AND METHODS--Untreated men and women (mean age 55 [+ or -] 1 year; BMI 32.3 [+ or -] 0.5 kg/[m.sup.2]) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. RESULTS--Body weight decreased by -7.1 [+ or -] 0.6 and -8.4 [+ or -] 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 [+ or -] 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 [+ or -] 30 and -101 [+ or -] 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 [+ or -] 6 and -19 [+ or -] 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. CONCLUSIONS--The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.
Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function.OBJECTIVESympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function.Untreated men and women (mean age 55 +/- 1 year; BMI 32.3 +/- 0.5 kg/m(2)) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks.RESEARCH DESIGN AND METHODSUntreated men and women (mean age 55 +/- 1 year; BMI 32.3 +/- 0.5 kg/m(2)) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks.Body weight decreased by -7.1 +/- 0.6 and -8.4 +/- 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 +/- 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 +/- 30 and -101 +/- 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 +/- 6 and -19 +/- 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups.RESULTSBody weight decreased by -7.1 +/- 0.6 and -8.4 +/- 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 +/- 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 +/- 30 and -101 +/- 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 +/- 6 and -19 +/- 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups.The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.CONCLUSIONSThe addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.
Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine the effects of lifestyle interventions (weight loss alone or together with exercise) on SNS function. Untreated men and women (mean age 55 +/- 1 year; BMI 32.3 +/- 0.5 kg/m(2)) who fulfilled Adult Treatment Panel III metabolic syndrome criteria were randomly allocated to either dietary weight loss (WL, n = 20), dietary weight loss and moderate-intensity aerobic exercise (WL+EX, n = 20), or no treatment (control, n = 19). Whole-body norepinephrine kinetics, muscle sympathetic nerve activity by microneurography, baroreflex sensitivity, fitness (maximal oxygen consumption), metabolic, and anthropometric measurements were made at baseline and 12 weeks. Body weight decreased by -7.1 +/- 0.6 and -8.4 +/- 1.0 kg in the WL and WL+EX groups, respectively (both P < 0.001). Fitness increased by 19 +/- 4% (P < 0.001) in the WL+EX group only. Resting SNS activity decreased similarly in the WL and WL+EX groups: norepinephrine spillover by -96 +/- 30 and -101 +/- 34 ng/min (both P < 0.01) and muscle sympathetic nerve activity by -12 +/- 6 and -19 +/- 4 bursts/100 heart beats, respectively (both P < 0.01), but remained unchanged in control subjects. Blood pressure, baroreflex sensitivity, and metabolic parameters improved significantly and similarly in the two lifestyle intervention groups. The addition of moderate-intensity aerobic exercise training to a weight loss program does not confer additional benefits on resting SNS activity. This suggests that weight loss is the prime mover in sympathetic neural adaptation to a hypocaloric diet.
Audience Professional
Author Gavin W. Lambert
Mariee T. McGrane
Elisabeth A. Lambert
Tye Dawood
Reena Chopra
Paul J. Nestel
Nora E. Straznicky
Florentia Socratous
Nina Eikelis
Barbora de Courten
Murray D. Esler
Markus P. Schlaich
Carolina I. Sari
Eldho Paul
Kazuko Masuo
Justin A. Mariani
Author_xml – sequence: 1
  givenname: Nora E.
  surname: Straznicky
  fullname: Straznicky, Nora E.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 2
  givenname: Elisabeth A.
  surname: Lambert
  fullname: Lambert, Elisabeth A.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 3
  givenname: Paul J.
  surname: Nestel
  fullname: Nestel, Paul J.
  organization: Cardiovascular Nutrition Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 4
  givenname: Mariee T.
  surname: McGrane
  fullname: McGrane, Mariee T.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 5
  givenname: Tye
  surname: Dawood
  fullname: Dawood, Tye
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 6
  givenname: Markus P.
  surname: Schlaich
  fullname: Schlaich, Markus P.
  organization: Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 7
  givenname: Kazuko
  surname: Masuo
  fullname: Masuo, Kazuko
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 8
  givenname: Nina
  surname: Eikelis
  fullname: Eikelis, Nina
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 9
  givenname: Barbora
  surname: de Courten
  fullname: de Courten, Barbora
  organization: Clinical Physiology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 10
  givenname: Justin A.
  surname: Mariani
  fullname: Mariani, Justin A.
  organization: Heart Failure Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 11
  givenname: Murray D.
  surname: Esler
  fullname: Esler, Murray D.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 12
  givenname: Florentia
  surname: Socratous
  fullname: Socratous, Florentia
  organization: Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 13
  givenname: Reena
  surname: Chopra
  fullname: Chopra, Reena
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 14
  givenname: Carolina I.
  surname: Sari
  fullname: Sari, Carolina I.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
– sequence: 15
  givenname: Eldho
  surname: Paul
  fullname: Paul, Eldho
  organization: Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
– sequence: 16
  givenname: Gavin W.
  surname: Lambert
  fullname: Lambert, Gavin W.
  organization: Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22336751$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19833893$$D View this record in MEDLINE/PubMed
BookMark eNp9kkuP0zAUhSM0iHnAgj-AIhBCLDIT5-V4g1SVYQap0EUHwc5ynJvUVWJ3bAfaf88tLR2KCvLCkfPdY597z3lwoo2GIHhO4sskTelVXcUsilmaPQrOCEtZlCb020lwFsckiQhl9DQ4d24Rx3GB60lwSliZpiVLz4LVbN0vhZ-DVzL8DIMVXTiqxdILr4wOvQlv10sjRWcsAu8V-PCr8vPQ2F-7GXx4vQIrlYPwzgqllW5DpcNpBXjyCbyoTIeVs7WurekhnA3VAqR3T4PHjegcPNvtF8GXD9d349toMr35OB5NIllkiY9KWiUNlAVpZJVD3tSyFDWhJW1yQvKijjOZlHEOFWuyJK8rWQtGSFHEQAQVgqQXwbut7nKoeqglaI8e-dKqXtg1N0Lxwz9azXlrvvME-8YyigJvdgLW3A_gPO-Vk9B1QoMZHKfYyYyRPEPy5V_kwgxWozuekAKlsjJB6NUWakUHXOnG4K1yI8lHSBE0k5dIRUeoFjTgE3H4jcLjA_7yCI-rhl7JowVvDwqQ8bDyrRic4-XN5H-P2bHSdB20wHFc4-kh_-LPlu97_Tt1CLzeAcJhtBorNAZozyUY6oLmm9ldbTlpjXMWGi7VNpjoTnWcxHyTf77JP9_k_8HWvmJ_-b_ZuWrnP5QFXitRgQf38JEzTjgl6U_yJxFz
CODEN DIAEAZ
CitedBy_id crossref_primary_10_1016_j_atherosclerosis_2016_11_032
crossref_primary_10_1161_HYPERTENSIONAHA_118_11676
crossref_primary_10_1038_ijo_2011_170
crossref_primary_10_1210_en_2013_1382
crossref_primary_10_1371_journal_pone_0081692
crossref_primary_10_3390_nu11071667
crossref_primary_10_1016_j_jash_2018_06_007
crossref_primary_10_30934_kusbed_1090066
crossref_primary_10_1016_j_advnut_2022_10_001
crossref_primary_10_1186_s12933_017_0590_y
crossref_primary_10_3390_nu16142209
crossref_primary_10_1080_10408398_2022_2064424
crossref_primary_10_1002_oby_21126
crossref_primary_10_1038_s41598_021_83472_x
crossref_primary_10_1097_HCO_0000000000000749
crossref_primary_10_35277_kama_2011_13_2_273
crossref_primary_10_1155_2015_341583
crossref_primary_10_1111_cen_12003
crossref_primary_10_1161_HYPERTENSIONAHA_110_155663
crossref_primary_10_1186_1758_5996_6_127
crossref_primary_10_1016_j_clnu_2020_06_029
crossref_primary_10_1016_j_biocel_2019_01_004
crossref_primary_10_1186_s12933_015_0276_2
crossref_primary_10_7600_jspfsm_63_333
crossref_primary_10_1038_s41569_020_00437_9
crossref_primary_10_1152_ajpheart_00096_2015
crossref_primary_10_1253_circrep_CR_20_0050
crossref_primary_10_3389_fnins_2020_00841
crossref_primary_10_3810_hp_2011_10_924
crossref_primary_10_1016_j_metabol_2012_09_005
crossref_primary_10_1016_j_bone_2018_03_025
crossref_primary_10_3389_fphys_2016_00516
crossref_primary_10_1007_s40279_018_0897_1
crossref_primary_10_1093_ajh_hps050
crossref_primary_10_1111_obr_12501
crossref_primary_10_1097_GME_0b013e3182831ee4
crossref_primary_10_7570_jomes_2019_28_4_278
crossref_primary_10_1038_jhh_2011_66
crossref_primary_10_3390_nu11122849
crossref_primary_10_1152_japplphysiol_00060_2024
crossref_primary_10_3390_nu12051438
crossref_primary_10_1097_HJH_0b013e32833778e1
crossref_primary_10_1152_ajpheart_00115_2023
crossref_primary_10_3389_fphys_2017_00101
crossref_primary_10_1016_j_maturitas_2016_03_022
crossref_primary_10_1016_j_jand_2017_06_361
crossref_primary_10_1186_1475_2840_10_42
crossref_primary_10_1016_j_mehy_2013_07_018
crossref_primary_10_1038_oby_2011_303
crossref_primary_10_1007_s11906_011_0186_y
crossref_primary_10_1016_j_autneu_2016_11_002
crossref_primary_10_1097_HJH_0b013e3283418875
crossref_primary_10_1111_nyas_14140
crossref_primary_10_3390_nu11112721
crossref_primary_10_1038_s41392_023_01430_7
crossref_primary_10_1186_1471_2288_12_120
crossref_primary_10_1002_dmrr_1023
crossref_primary_10_1007_s00424_021_02651_x
crossref_primary_10_1111_j_1463_1326_2011_01497_x
crossref_primary_10_1016_S1443_9506_18_30002_7
crossref_primary_10_1002_oby_20614
crossref_primary_10_1007_s00259_019_04658_0
crossref_primary_10_1056_NEJMct0911013
crossref_primary_10_1080_10408398_2021_1873732
crossref_primary_10_1111_j_1467_789X_2010_00791_x
crossref_primary_10_1161_ATVBAHA_117_310212
crossref_primary_10_1080_10408398_2021_1999201
crossref_primary_10_1113_jphysiol_2010_190124
crossref_primary_10_1210_jc_2010_2204
crossref_primary_10_1016_j_rccar_2016_01_033
crossref_primary_10_1038_hr_2011_134
crossref_primary_10_3390_medicina60081223
crossref_primary_10_1016_j_ijcard_2015_09_031
crossref_primary_10_1161_HYPERTENSIONAHA_112_198002
crossref_primary_10_1016_S2213_8587_14_70033_6
crossref_primary_10_51789_cmsj_2021_1_e3
crossref_primary_10_3389_fphys_2021_754731
crossref_primary_10_3390_Obesities1010003
crossref_primary_10_3390_nu11112749
crossref_primary_10_3390_molecules26113168
crossref_primary_10_1172_jci_insight_164221
crossref_primary_10_1111_cpf_12095
crossref_primary_10_1093_ije_dyz244
crossref_primary_10_1016_j_atherosclerosis_2018_05_002
crossref_primary_10_1016_j_autneu_2014_10_020
crossref_primary_10_3390_ijerph16183481
crossref_primary_10_1111_obr_12241
Cites_doi 10.1161/01.HYP.23.3.294
10.1111/j.1600-0838.2006.00631.x
10.1161/01.CIR.103.20.2424
10.1210/jc.2006-0513
10.2337/diacare.28.7.1769
10.1161/01.HYP.21.5.618
10.1161/01.HYP.35.3.807
10.2337/diabetes.47.6.913
10.1038/sj.ijo.0802645
10.1152/ajpregu.90936.2008
10.2337/diacare.22.9.1462
10.1056/NEJM199704173361601
10.1161/01.CIR.0000033519.45615.C7
10.1097/00004872-199403000-00011
10.1161/CIRCULATIONAHA.105.169404
10.1093/ajcn/73.2.240
10.1161/01.CIR.91.10.2596
10.1007/s00125-005-1798-z
10.1016/0024-3205(79)90371-0
10.1152/ajpheart.01090.2002
10.1161/01.CIR.0000081775.72651.B6
10.1093/ajcn/84.5.1033
10.1681/ASN.2008040402
10.1097/00041433-200002000-00010
10.1001/archinte.158.22.2477
10.1002/clc.4960131104
10.1007/s11906-008-0083-1
10.1113/jphysiol.1949.sp004363
10.1097/HJH.0b013e328048d004
10.1152/jappl.1996.81.1.318
10.7326/0003-4819-142-8-200504190-00009
10.1152/ajpendo.00102.2007
10.1139/y89-003
10.1161/01.CIR.73.1.30
10.1161/01.HYP.0000091371.53502.D3
10.1161/01.CIR.0000041244.79165.25
10.1172/JCI115260
10.1016/0002-9343(93)90253-L
10.1056/NEJM200101043440101
10.1053/meta.2001.19502
10.1177/153537020122600508
10.1007/s11906-004-0075-8
10.1161/01.CIR.97.20.2037
10.1152/ajpendo.00487.2004
10.1016/0140-6736(91)93056-F
10.1161/01.HYP.18.5.575
10.1097/01.hjh.0000125469.35523.32
10.1210/jc.2005-0961
10.1016/j.metabol.2008.05.012
10.1093/ajcn/79.4.544
ClassificationCodes 8000141
ContentType Journal Article
Copyright 2015 INIST-CNRS
COPYRIGHT 2010 American Diabetes Association
COPYRIGHT 2010 American Diabetes Association
Copyright American Diabetes Association Jan 2010
2010 by the American Diabetes Association.
Copyright_xml – notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2010 American Diabetes Association
– notice: COPYRIGHT 2010 American Diabetes Association
– notice: Copyright American Diabetes Association Jan 2010
– notice: 2010 by the American Diabetes Association.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
5PM
DOI 10.2337/db09-0934
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database (NC LIVE)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
ProQuest Public Health Database (NC LIVE)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database (Proquest)
eLibrary Curriculum
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni)
Medical Database
Proquest Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Research Library Prep


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 79
ExternalDocumentID PMC2797947
1958256381
A216180558
19833893
22336751
10_2337_db09_0934
diabetes_59_1_71
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
53G
55
5GY
5RE
5RS
5VS
7RV
7X7
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAQQT
AAWTL
AAYEP
AAYJJ
ABFLS
ABOCM
ABPTK
ABUWG
ACDCL
ACGOD
ACPRK
ADACO
ADBBV
ADBIT
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BBNVY
BCR
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EX3
F5P
FRP
FYUFA
GICCO
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
H~9
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
K-O
K9-
KM
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5
M7P
MBDVC
O0-
O5R
O5S
O9-
OB3
OBH
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
WH7
WOQ
WOW
X7M
XZ
ZA5
ZY1
---
.55
.XZ
08P
0R~
18M
354
6PF
AAFWJ
AAKAS
AAYOK
AAYXX
ACGFO
ADGHP
ADZCM
AEGXH
AERZD
AIAGR
AIZAD
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
ITC
K2M
M5~
N4W
NAPCQ
OHH
PHGZM
PHGZT
TEORI
TR2
UKHRP
VVN
W8F
YFH
YHG
YOC
~KM
.GJ
1CY
8F7
AFFNX
AI.
IQODW
J5H
MVM
PJZUB
PPXIY
PQGLB
VH1
XOL
YQJ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PKEHL
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c642t-87b2fe861fcb5e5fdc8ad1787f51156d04c2805eb9f425dbcda911660e1a7aa13
IEDL.DBID 7X7
ISSN 0012-1797
1939-327X
IngestDate Thu Aug 21 18:16:43 EDT 2025
Fri Sep 05 05:29:08 EDT 2025
Fri Jul 25 11:01:18 EDT 2025
Tue Jun 17 20:38:29 EDT 2025
Thu Jun 12 23:55:21 EDT 2025
Tue Jun 10 20:33:06 EDT 2025
Fri Jun 27 04:57:13 EDT 2025
Tue Jun 10 20:05:31 EDT 2025
Mon Jul 21 06:00:37 EDT 2025
Mon Jul 21 09:17:01 EDT 2025
Thu Apr 24 23:01:50 EDT 2025
Tue Jul 01 03:04:02 EDT 2025
Fri Jan 15 19:45:57 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Endocrinopathy
Physical exercise
Human
Obesity
Diabetes mellitus
Nutrition disorder
Metabolic diseases
Cardiovascular disease
Metabolic syndrome
Sympathetic nervous system
Feeding
Diet
Autonomic nervous system
Nutritional status
Adaptation
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-87b2fe861fcb5e5fdc8ad1787f51156d04c2805eb9f425dbcda911660e1a7aa13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2797947
PMID 19833893
PQID 216473482
PQPubID 34443
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2797947
gale_infotracacademiconefile_A216180558
gale_incontextgauss_8GL_A216180558
pascalfrancis_primary_22336751
pubmed_primary_19833893
gale_infotracgeneralonefile_A216180558
crossref_citationtrail_10_2337_db09_0934
highwire_diabetes_diabetes_59_1_71
proquest_journals_216473482
gale_infotracmisc_A216180558
proquest_miscellaneous_733849154
gale_incontextcollege_GICCO_A216180558
crossref_primary_10_2337_db09_0934
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-01-01
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2010
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Lee (2022031210413868300_B4) 2001; 50
Alvarez (2022031210413868300_B8) 2002; 106
Sacks (2022031210413868300_B44) 2001; 344
Mancia (2022031210413868300_B3) 2007; 25
Somers (2022031210413868300_B38) 1991; 337
Masuo (2022031210413868300_B9) 2003; 42
Grassi (2022031210413868300_B35) 1998; 97
Weiss (2022031210413868300_B33) 2006; 84
Fontana (2022031210413868300_B34) 2007; 293
Julius (2022031210413868300_B11) 2000; 35
Grassi (2022031210413868300_B41) 2004; 6
Grassi (2022031210413868300_B43) 2002; 106
Straznicky (2022031210413868300_B7) 2008; 10
Grassi (2022031210413868300_B18) 1994; 23
Esler (2022031210413868300_B30) 1979; 25
Jennings (2022031210413868300_B49) 1986; 73
Parati (2022031210413868300_B31) 2004; 22
Schlaich (2022031210413868300_B14) 2003; 108
Svendsen (2022031210413868300_B20) 1993; 95
Grundy (2022031210413868300_B25) 2005; 112
Matsuda (2022031210413868300_B32) 1999; 22
Nash (2022031210413868300_B47) 1990; 13
Orchard (2022031210413868300_B16) 2005; 142
Trombetta (2022031210413868300_B23) 2003; 285
Schlaich (2022031210413868300_B15) 2009; 20
Meredith (2022031210413868300_B19) 1991; 18
Nicklas (2022031210413868300_B48) 2004; 79
Akehi (2022031210413868300_B36) 2001; 226
Anderson (2022031210413868300_B42) 1991; 87
Straznicky (2022031210413868300_B5) 2005; 90
Dengel (2022031210413868300_B24) 1996; 81
Heffernan (2022031210413868300_B50) 2009; 296
Weir (2022031210413868300_B28) 1949; 109
Grundy (2022031210413868300_B2) 2007; 92
Ford (2022031210413868300_B1) 2005; 28
Van Harmelen (2022031210413868300_B40) 1998; 47
Howard (2022031210413868300_B13) 2004; 28
Jamerson (2022031210413868300_B12) 1993; 21
Reseland (2022031210413868300_B21) 2001; 73
Grassi (2022031210413868300_B6) 2005; 48
Alvarez (2022031210413868300_B37) 2005; 289
Anderssen (2022031210413868300_B17) 2007; 17
Hunt (2022031210413868300_B39) 2001; 103
Weinstock (2022031210413868300_B22) 1998; 158
King (2022031210413868300_B26) 1995; 91
Reid (2022031210413868300_B46) 1994; 12
Appel (2022031210413868300_B27) 1997; 336
Poehlman (2022031210413868300_B29) 1989; 67
Flaa (2022031210413868300_B10) 2008; 57
Noakes (2022031210413868300_B45) 2000; 11
8125553 - Hypertension. 1994 Mar;23(3):294-301
17093155 - Am J Clin Nutr. 2006 Nov;84(5):1033-42
18799718 - J Am Soc Nephrol. 2009 May;20(5):933-9
3510088 - Circulation. 1986 Jan;73(1):30-40
11393172 - Exp Biol Med (Maywood). 2001 May;226(5):440-5
1674761 - Lancet. 1991 Jun 8;337(8754):1363-8
17331082 - Scand J Med Sci Sports. 2007 Dec;17(6):687-95
8491496 - Hypertension. 1993 May;21(5):618-23
15051595 - Am J Clin Nutr. 2004 Apr;79(4):544-51
12427647 - Circulation. 2002 Nov 12;106(20):2533-6
18959829 - Curr Hypertens Rep. 2008 Dec;10(6):440-7
10720599 - Hypertension. 2000 Mar;35(3):807-13
12953019 - Hypertension. 2003 Oct;42(4):474-80
17389710 - Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E197-202
11157319 - Am J Clin Nutr. 2001 Feb;73(2):240-5
12714324 - Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H974-82
17414649 - J Hypertens. 2007 May;25(5):909-20
1980236 - Clin Cardiol. 1990 Nov;13(11):764-72
9099655 - N Engl J Med. 1997 Apr 17;336(16):1117-24
9855386 - Arch Intern Med. 1998 Dec 7-21;158(22):2477-83
513964 - Life Sci. 1979 Oct 22;25(17):1461-70
15201539 - J Hypertens. 2004 Jul;22(7):1259-63
8356979 - Am J Med. 1993 Aug;95(2):131-40
15254486 - Int J Obes Relat Metab Disord. 2004 Aug;28(8):1039-47
10750696 - Curr Opin Lipidol. 2000 Feb;11(1):65-70
15394301 - J Physiol. 1949 Aug;109(1-2):1-9
11369680 - Circulation. 2001 May 22;103(20):2424-7
2040704 - J Clin Invest. 1991 Jun;87(6):2246-52
1937659 - Hypertension. 1991 Nov;18(5):575-82
15941781 - Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E665-9
11136953 - N Engl J Med. 2001 Jan 4;344(1):3-10
16091482 - J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005
7743622 - Circulation. 1995 May 15;91(10):2596-604
9610534 - Circulation. 1998 May 26;97(20):2037-42
2653593 - Can J Physiol Pharmacol. 1989 Jan;67(1):10-6
10480510 - Diabetes Care. 1999 Sep;22(9):1462-70
15128478 - Curr Hypertens Rep. 2004 Jun;6(3):236-40
8828680 - J Appl Physiol (1985). 1996 Jul;81(1):318-25
15838067 - Ann Intern Med. 2005 Apr 19;142(8):611-9
15983333 - Diabetes Care. 2005 Jul;28(7):1769-78
11229419 - Metabolism. 2001 Feb;50(2):135-43
12370219 - Circulation. 2002 Oct 8;106(15):1957-61
15933859 - Diabetologia. 2005 Jul;48(7):1359-65
18803948 - Metabolism. 2008 Oct;57(10):1422-7
19193941 - Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1098-105
8021483 - J Hypertens. 1994 Mar;12(3):291-301
9604868 - Diabetes. 1998 Jun;47(6):913-7
12847071 - Circulation. 2003 Aug 5;108(5):560-5
17284640 - J Clin Endocrinol Metab. 2007 Feb;92(2):399-404
16157765 - Circulation. 2005 Oct 25;112(17):2735-52
References_xml – volume: 23
  start-page: 294
  year: 1994
  ident: 2022031210413868300_B18
  article-title: Physical training and baroreceptor control of sympathetic nerve activity in humans
  publication-title: Hypertension
  doi: 10.1161/01.HYP.23.3.294
– volume: 17
  start-page: 687
  year: 2007
  ident: 2022031210413868300_B17
  article-title: Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study
  publication-title: Scand J Med Sci Sports
  doi: 10.1111/j.1600-0838.2006.00631.x
– volume: 103
  start-page: 2424
  year: 2001
  ident: 2022031210413868300_B39
  article-title: Does reduced vascular stiffening fully explain preserved cardiovagal baroreflex function in older, physically active men?
  publication-title: Circulation
  doi: 10.1161/01.CIR.103.20.2424
– volume: 92
  start-page: 399
  year: 2007
  ident: 2022031210413868300_B2
  article-title: Metabolic syndrome: a multiplex cardiovascular risk factor
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-0513
– volume: 28
  start-page: 1769
  year: 2005
  ident: 2022031210413868300_B1
  article-title: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence
  publication-title: Diabetes Care
  doi: 10.2337/diacare.28.7.1769
– volume: 21
  start-page: 618
  year: 1993
  ident: 2022031210413868300_B12
  article-title: Reflex sympathetic activation induces acute insulin resistance in the human forearm
  publication-title: Hypertension
  doi: 10.1161/01.HYP.21.5.618
– volume: 35
  start-page: 807
  year: 2000
  ident: 2022031210413868300_B11
  article-title: Overweight and hypertension: a 2-way street?
  publication-title: Hypertension
  doi: 10.1161/01.HYP.35.3.807
– volume: 47
  start-page: 913
  year: 1998
  ident: 2022031210413868300_B40
  article-title: Leptin secretion from subcutaneous and visceral adipose tissue in women
  publication-title: Diabetes
  doi: 10.2337/diabetes.47.6.913
– volume: 28
  start-page: 1039
  year: 2004
  ident: 2022031210413868300_B13
  article-title: Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups
  publication-title: Int J Obes
  doi: 10.1038/sj.ijo.0802645
– volume: 296
  start-page: R1098
  year: 2009
  ident: 2022031210413868300_B50
  article-title: C-reactive protein and cardiac vagal activity following resistance exercise training in young African-American and white men
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.90936.2008
– volume: 22
  start-page: 1462
  year: 1999
  ident: 2022031210413868300_B32
  article-title: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
  publication-title: Diabetes Care
  doi: 10.2337/diacare.22.9.1462
– volume: 336
  start-page: 1117
  year: 1997
  ident: 2022031210413868300_B27
  article-title: A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199704173361601
– volume: 106
  start-page: 1957
  year: 2002
  ident: 2022031210413868300_B43
  article-title: Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000033519.45615.C7
– volume: 12
  start-page: 291
  year: 1994
  ident: 2022031210413868300_B46
  article-title: Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects
  publication-title: J Hypertens
  doi: 10.1097/00004872-199403000-00011
– volume: 112
  start-page: 2735
  year: 2005
  ident: 2022031210413868300_B25
  article-title: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.169404
– volume: 73
  start-page: 240
  year: 2001
  ident: 2022031210413868300_B21
  article-title: Effect of long-term changes in diet and exercise on plasma leptin concentrations
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/73.2.240
– volume: 91
  start-page: 2596
  year: 1995
  ident: 2022031210413868300_B26
  article-title: Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.10.2596
– volume: 48
  start-page: 1359
  year: 2005
  ident: 2022031210413868300_B6
  article-title: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome
  publication-title: Diabetologia
  doi: 10.1007/s00125-005-1798-z
– volume: 25
  start-page: 1461
  year: 1979
  ident: 2022031210413868300_B30
  article-title: Determination of norepinephrine apparent release rate and clearance in humans
  publication-title: Life Sci
  doi: 10.1016/0024-3205(79)90371-0
– volume: 285
  start-page: H974
  year: 2003
  ident: 2022031210413868300_B23
  article-title: Weight loss improves neurovascular and muscle metaboreflex control in obesity
  publication-title: Am J Heart Circ Physiol
  doi: 10.1152/ajpheart.01090.2002
– volume: 108
  start-page: 560
  year: 2003
  ident: 2022031210413868300_B14
  article-title: Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000081775.72651.B6
– volume: 84
  start-page: 1033
  year: 2006
  ident: 2022031210413868300_B33
  article-title: Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/84.5.1033
– volume: 20
  start-page: 933
  year: 2009
  ident: 2022031210413868300_B15
  article-title: Sympathetic activation in chronic renal failure: causes, consequences and therapeutic implications
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008040402
– volume: 11
  start-page: 65
  year: 2000
  ident: 2022031210413868300_B45
  article-title: Weight loss and plasma lipids
  publication-title: Curr Opin Lipidol
  doi: 10.1097/00041433-200002000-00010
– volume: 158
  start-page: 2477
  year: 1998
  ident: 2022031210413868300_B22
  article-title: Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.158.22.2477
– volume: 13
  start-page: 764
  year: 1990
  ident: 2022031210413868300_B47
  article-title: Alpha-adrenergic blockers: mechanisms of action, blood pressure control, and effects of lipoprotein metabolism
  publication-title: Clin Cardiol
  doi: 10.1002/clc.4960131104
– volume: 10
  start-page: 440
  year: 2008
  ident: 2022031210413868300_B7
  article-title: Mediators of sympathetic activation in metabolic syndrome obesity
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-008-0083-1
– volume: 109
  start-page: 1
  year: 1949
  ident: 2022031210413868300_B28
  article-title: New methods for calculating metabolic rate with special reference to protein metabolism
  publication-title: J Physiol
  doi: 10.1113/jphysiol.1949.sp004363
– volume: 25
  start-page: 909
  year: 2007
  ident: 2022031210413868300_B3
  article-title: The sympathetic nervous system and the metabolic syndrome
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e328048d004
– volume: 81
  start-page: 318
  year: 1996
  ident: 2022031210413868300_B24
  article-title: Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.1996.81.1.318
– volume: 142
  start-page: 611
  year: 2005
  ident: 2022031210413868300_B16
  article-title: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-142-8-200504190-00009
– volume: 293
  start-page: E197
  year: 2007
  ident: 2022031210413868300_B34
  article-title: Calorie restriction or exercise: effects on coronary heart disease risk factors: a randomized, controlled trial
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00102.2007
– volume: 67
  start-page: 10
  year: 1989
  ident: 2022031210413868300_B29
  article-title: The effect of prior exercise and caffeine ingestion on metabolic rate and hormones in young adult males
  publication-title: Can J Physiol Pharmacol
  doi: 10.1139/y89-003
– volume: 73
  start-page: 30
  year: 1986
  ident: 2022031210413868300_B49
  article-title: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity
  publication-title: Circulation
  doi: 10.1161/01.CIR.73.1.30
– volume: 42
  start-page: 474
  year: 2003
  ident: 2022031210413868300_B9
  article-title: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000091371.53502.D3
– volume: 106
  start-page: 2533
  year: 2002
  ident: 2022031210413868300_B8
  article-title: Sympathetic neural activation in visceral obesity
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000041244.79165.25
– volume: 87
  start-page: 2246
  year: 1991
  ident: 2022031210413868300_B42
  article-title: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans
  publication-title: J Clin Invest
  doi: 10.1172/JCI115260
– volume: 95
  start-page: 131
  year: 1993
  ident: 2022031210413868300_B20
  article-title: Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women
  publication-title: Am J Med
  doi: 10.1016/0002-9343(93)90253-L
– volume: 344
  start-page: 3
  year: 2001
  ident: 2022031210413868300_B44
  article-title: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200101043440101
– volume: 50
  start-page: 135
  year: 2001
  ident: 2022031210413868300_B4
  article-title: Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese
  publication-title: Metabolism
  doi: 10.1053/meta.2001.19502
– volume: 226
  start-page: 440
  year: 2001
  ident: 2022031210413868300_B36
  article-title: D-induced weight loss improves heart rate variability in moderately obese Japanese
  publication-title: Exp Biol Med
  doi: 10.1177/153537020122600508
– volume: 6
  start-page: 236
  year: 2004
  ident: 2022031210413868300_B41
  article-title: Leptin, sympathetic nervous system, and baroreflex function
  publication-title: Curr Hypertens Rep
  doi: 10.1007/s11906-004-0075-8
– volume: 97
  start-page: 2037
  year: 1998
  ident: 2022031210413868300_B35
  article-title: Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.20.2037
– volume: 289
  start-page: E665
  year: 2005
  ident: 2022031210413868300_B37
  article-title: Weight loss increases cardiovagal baroreflex function in obese young and older men
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00487.2004
– volume: 337
  start-page: 1363
  year: 1991
  ident: 2022031210413868300_B38
  article-title: Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension
  publication-title: Lancet
  doi: 10.1016/0140-6736(91)93056-F
– volume: 18
  start-page: 575
  year: 1991
  ident: 2022031210413868300_B19
  article-title: Exercise training lowers resting renal but not cardiac sympathetic activity in humans
  publication-title: Hypertension
  doi: 10.1161/01.HYP.18.5.575
– volume: 22
  start-page: 1259
  year: 2004
  ident: 2022031210413868300_B31
  article-title: Assessing arterial baroreflex control of heart rate: new perspectives
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000125469.35523.32
– volume: 90
  start-page: 5998
  year: 2005
  ident: 2022031210413868300_B5
  article-title: Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0961
– volume: 57
  start-page: 1422
  year: 2008
  ident: 2022031210413868300_B10
  article-title: Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2008.05.012
– volume: 79
  start-page: 544
  year: 2004
  ident: 2022031210413868300_B48
  article-title: Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.4.544
– reference: 15128478 - Curr Hypertens Rep. 2004 Jun;6(3):236-40
– reference: 10720599 - Hypertension. 2000 Mar;35(3):807-13
– reference: 15201539 - J Hypertens. 2004 Jul;22(7):1259-63
– reference: 1980236 - Clin Cardiol. 1990 Nov;13(11):764-72
– reference: 11136953 - N Engl J Med. 2001 Jan 4;344(1):3-10
– reference: 18799718 - J Am Soc Nephrol. 2009 May;20(5):933-9
– reference: 9099655 - N Engl J Med. 1997 Apr 17;336(16):1117-24
– reference: 17389710 - Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E197-202
– reference: 11229419 - Metabolism. 2001 Feb;50(2):135-43
– reference: 11369680 - Circulation. 2001 May 22;103(20):2424-7
– reference: 513964 - Life Sci. 1979 Oct 22;25(17):1461-70
– reference: 3510088 - Circulation. 1986 Jan;73(1):30-40
– reference: 8828680 - J Appl Physiol (1985). 1996 Jul;81(1):318-25
– reference: 8491496 - Hypertension. 1993 May;21(5):618-23
– reference: 2040704 - J Clin Invest. 1991 Jun;87(6):2246-52
– reference: 15394301 - J Physiol. 1949 Aug;109(1-2):1-9
– reference: 17284640 - J Clin Endocrinol Metab. 2007 Feb;92(2):399-404
– reference: 2653593 - Can J Physiol Pharmacol. 1989 Jan;67(1):10-6
– reference: 18959829 - Curr Hypertens Rep. 2008 Dec;10(6):440-7
– reference: 12714324 - Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H974-82
– reference: 12847071 - Circulation. 2003 Aug 5;108(5):560-5
– reference: 1937659 - Hypertension. 1991 Nov;18(5):575-82
– reference: 16091482 - J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005
– reference: 19193941 - Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1098-105
– reference: 1674761 - Lancet. 1991 Jun 8;337(8754):1363-8
– reference: 8125553 - Hypertension. 1994 Mar;23(3):294-301
– reference: 15933859 - Diabetologia. 2005 Jul;48(7):1359-65
– reference: 8021483 - J Hypertens. 1994 Mar;12(3):291-301
– reference: 7743622 - Circulation. 1995 May 15;91(10):2596-604
– reference: 10480510 - Diabetes Care. 1999 Sep;22(9):1462-70
– reference: 11157319 - Am J Clin Nutr. 2001 Feb;73(2):240-5
– reference: 17414649 - J Hypertens. 2007 May;25(5):909-20
– reference: 9855386 - Arch Intern Med. 1998 Dec 7-21;158(22):2477-83
– reference: 15983333 - Diabetes Care. 2005 Jul;28(7):1769-78
– reference: 15941781 - Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E665-9
– reference: 17331082 - Scand J Med Sci Sports. 2007 Dec;17(6):687-95
– reference: 12370219 - Circulation. 2002 Oct 8;106(15):1957-61
– reference: 15051595 - Am J Clin Nutr. 2004 Apr;79(4):544-51
– reference: 18803948 - Metabolism. 2008 Oct;57(10):1422-7
– reference: 10750696 - Curr Opin Lipidol. 2000 Feb;11(1):65-70
– reference: 12953019 - Hypertension. 2003 Oct;42(4):474-80
– reference: 12427647 - Circulation. 2002 Nov 12;106(20):2533-6
– reference: 9610534 - Circulation. 1998 May 26;97(20):2037-42
– reference: 16157765 - Circulation. 2005 Oct 25;112(17):2735-52
– reference: 17093155 - Am J Clin Nutr. 2006 Nov;84(5):1033-42
– reference: 8356979 - Am J Med. 1993 Aug;95(2):131-40
– reference: 15838067 - Ann Intern Med. 2005 Apr 19;142(8):611-9
– reference: 9604868 - Diabetes. 1998 Jun;47(6):913-7
– reference: 11393172 - Exp Biol Med (Maywood). 2001 May;226(5):440-5
– reference: 15254486 - Int J Obes Relat Metab Disord. 2004 Aug;28(8):1039-47
SSID ssj0006060
Score 2.3100278
Snippet Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects Nora E. Straznicky 1 , Elisabeth A....
Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to examine...
OBJECTIVE--Sympathetic nervous system (SNS) overactivity contributes to the pathogenesis and target organ complications of obesity. This study was conducted to...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 71
SubjectTerms Acclimatization - physiology
Aerobic exercises
Aerobics
Aerobiosis
Biological and medical sciences
Blood Pressure
Body Size
Body Weight
Care and treatment
Diabetes
Diabetes. Impaired glucose tolerance
Diet
Diet, Reducing
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Exercise
Female
Fitness training programs
Fundamental and applied biological sciences. Psychology
Health aspects
Humans
Hypertension
Insulin resistance
Intervention
Life Style
Lifestyles
Male
Medical sciences
Metabolic diseases
Metabolic syndrome
Metabolic Syndrome - complications
Middle Aged
Miscellaneous
Muscle, Skeletal - physiopathology
Nervous system
Norepinephrine - metabolism
Obesity
Obesity - complications
Obesity - physiopathology
Obesity - rehabilitation
Original
Other metabolic disorders
Pathogenesis
Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ
Physical fitness
Research design
Sympathetic Nervous System - physiopathology
Treatment Outcome
Vertebrates: nervous system and sense organs
Weight control
Weight loss
Women
Title Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects
URI http://diabetes.diabetesjournals.org/content/59/1/71.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19833893
https://www.proquest.com/docview/216473482
https://www.proquest.com/docview/733849154
https://pubmed.ncbi.nlm.nih.gov/PMC2797947
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAviG_CRmUhNHiJlsRJ7DyhUToqRAdim-ibFX9kqzSSsqQS---5S5yMoIqXNlKujWOfz787n39HyBthwlgl4JYok8Z-nMVwBajZNwLAh-VIh4c7uouTdH4ef14mS5ebU7u0yt4mtobaVBpj5IcREl8hE8v79S8fi0bh5qqroHGX7IYARLByA18O_lYA2Lw7gRJGyMLJO2KhiDF-aBTuCWQsHi1HvVHumYIxUTKvoa-KrsjFNhT6bzLlX6vT8UPywMFKetTpwSNyx5aPyb2F2zh_Qn6f3vzE4sN4ZJEiIQcKm3zdbcTTpqLzmzUua0gZQj-ubEN_rJpLWl2339WmoTNXnImeuaoSdFVSrCtg6cI2oEtX8MtTR4BAwSBhhKd-Ss6PZ2fTue-KLvgaXJEGrKOKCivSsNAqsUlhtMhNCNO6AGiWpCaIdSSCxKqsgOlulDY52Ms0DWyY8zwP2TOyU1alfUFoUETaqjTKVQFeOOBjzoRRUQaLpYD-Zx551_e91I6RHAtjXEnwTHCYJA6TxGHyyOtBdN3RcGwTOsABlEhrUWLejO5iLxLeb_pVHkVYHCBIEgH_Nha8yDd1LcWnLyOht06oqKBVOnfnFeDdkDJrJHkwkrzoCMO3Ce6PBGEm63Gzes2TfeT99iLJZCh56JHJSCeH7gCcx8D7A4G9Xkmls0e1HGaPR-hwFx-PKXalrTa15IyJOANE7ZHnnUbf9nQmGAJbj_CRrg8CyFE-vlOuLluu8gjmXRbzl_9t1B653yVlYGRrn-w01xv7CrBeoybtjIZPMQ0nZPfD7OTb90kbkvsDOixW9A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxBu3pawQFC5W7fVrfUCoSltSmpRDU9Hb4n24jdTaoXYE-VH8R2aydoJRxK2nWPJnZ70zOzuzO_sNIW-59kMZQVgidRy6YRrCFXjNrubgfJgE6fBwR3d4EvfPwi_n0fka-d2ehcG0ytYmzg21LhWuke8yJL5CJpZPkx8uFo3CzdW2gobVimMz-wkRW_XxaB_E-46xw4NRr-82RQVcBa52DaNfstzw2M-VjEyUa8Uz7YPa5uB6RLH2QsW4FxmZ5qDOWiqdgT2IY8_4WZJlfgDvvUPu4kEjpOrnvWVGCcQC9sSLz5D1M7FERiwIkl0tcQ8iDcLO9NdOAi0zMSZmZhXIJrdFNVZ5vf8mb_41Gx4-Ig8bN5buWb17TNZM8YTcGzYb9U_Jr9PZNRY7xiOSFAlAEKyzid34p3VJ-7MJTqNIUUL3x6am38b1JS1v5r_ltKYHTTEoOmqqWNBxQbGOgaFDU4PuXsGTpw3hAgUDiCtK1TNydivyeE7Wi7IwLwn1cqaMjFkmc4j6wR9PAq4lS2Fy5tD_gUM-tH0vVMOAjoU4rgREQigmgWISKCaHvFlAJ5b2YxVoBwUokEajwDwdZdd6BHxf76vYY1iMwIsiDm_rAi-yaVUJ_nnQAb1vQHkJrVJZcz4Cvg0pujrInQ7ywhKUrwJudYBgOVS3Wa3miXalf3kRpcIXie-Q7Y5OLroD_MoAok0AbLZKKhr7V4nFaHUIXdzFv8eUvsKU00okQcDDFDx4h7ywGr3s6ZQH6Eg7JOno-gKAnOjdO8X4cs6NzmDcpWGy8d9GvSb3-6PhQAyOTo43yQObEIKraltkvb6ZmlfgZ9Zyez66Kfl-2-bkDyI-kQs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVqq4IN6YlrJCULhEsdfvQ4XaJiGlTahoK3pbvA-3kYodakeQn8i_6ky8djGKuPUUS_7srHdmZ2Z3Z78h5G2kHE_4MC0RKvA6XuzBFUTNHRVB8KFDpMPDHd3ROBieeZ_P_fMV8qc-C4NplbVNXBhqlUtcI-8yJL5CJpZuarIijnuDj9OfHSwghRutdTWNxFRZUDsLtjFzxuNQz3_BbK7YOeiB6N8xNuif7g87puBAR0IYXoJlECzVUeCkUvjaT5WMEuWASqcQlviBsj3JItvXIk5B1ZWQKgFbEQS2dpIwSRwX3nuPrIXg9GEeuLbXHx9_bdwCzBSq8zAOQ07QsKI5Yq4bdpXAHYrY9VrOsXYRNW8xpm0mBUgurUpuLIuJ_03t_MtXDh6SBybIpbuVVj4iKzp7TNZHZhv_Cfl9Mv-BpZDxACVFehAEq2RapQXQMqfD-RSdLBKY0N5El_TbpLyk-fXiN5-VtG9KRdFTU-OCTjKKVQ40HekSNPsKnjwxdAwUzCOuNxVPydmdSOQZWc3yTL8g1E6Z1CJgiUhtL4BoPXQjJVgMrjuC_nct8qHuey4NPzqW6bjiME9CMXEUE0cxWeRNA51WpCDLQNsoQI4kGxnqq6xWgjh83_4XvsuwVIHt-xG8rQ28SGZFwaNPRy3QewNKc2iVTMzpCfg2JPBqIbdbyIuKvnwZcLMFBLsi282qNY_X-wC3F37MHR46Ftlq6WTTHRB1ujAXBcBGraTcWMeCN2PZIrS5i3-PCX-ZzmcFD1038mKI7y3yvNLo256OIxfDbIuELV1vAMiY3r6TTS4XzOkMxl3shS__26jXZB1MCz86GB9ukPtVtgguuW2S1fJ6pl9BEFqKLTO8Kfl-1xblBr4onBs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sympathetic+neural+adaptation+to+hypocaloric+diet+with+or+without+exercise+training+in+obese+metabolic+syndrome+subjects&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Straznicky%2C+Nora+E&rft.au=Lambert%2C+Elisabeth+A&rft.au=Nestel%2C+Paul+J&rft.au=McGrane%2C+Mariee+T&rft.date=2010-01-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=59&rft.issue=1&rft.spage=71&rft_id=info:doi/10.2337%2Fdb09-0934&rft.externalDocID=A216180558
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon